Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer|January 16, 2019
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignanciesManish R Sharma, Smita S Joshi, Theodore G Karrison, et al.
Investigational New Drugs|January 21, 2017
Phase I study of lurbinectedin, a synthetic tetrahydroisoquinoline that inhibits activated transcription, induces DNA single- and double-strand breaks, on a weekly × 2 every-3-week scheduleAntonio Jimeno, Manish R Sharma, Sergio Szyldergemajn, et al.
Investigational New Drugs|May 10, 2011
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II ConsortiumManish R Sharma, Kristen Wroblewski, Blase N Polite, et al.
The Oncologist|October 25, 2018
A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Rebecca A Miksad, Mohamedtaki A Tejani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid TumorsPamela N Munster, Andrew E Greenstein, Gini F Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsManish R Sharma, Theodore G Karrison, Bethany Kell, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsAmikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.
The AAPS Journal|June 17, 2017
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)Shailly Mehrotra, Manish R Sharma, Elizabeth Gray, et al.
JCO Precision Oncology|July 17, 2018
Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of <i>POLD1</i> and <i>MLH1</i>Manish R Sharma, James T Auman, Nirali M Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using <i>UGT1A1</i> Genotype-Guided DosingSmita S Joshi, Daniel V T Catenacci, Theodore G Karrison, et al.
Pageof 5